Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
Honkanen H, Piaggio G, Hertzen H, Bártfai G, Erdenetungalag R, Gemzell-Danielsson K, Gopalan S, Horga M, Jerve F, Mittal S, Thi Nhu Ngoc N, Peregoudov A, Prasad RN, Pretnar-Darovec A, Shah RS, Song S, Tang OS, Wu SC; WHO Research Group on Post-Ovulatory Methods for Fertility Regulation. Honkanen H, et al. Among authors: pretnar darovec a. BJOG. 2004 Jul;111(7):715-25. doi: 10.1111/j.1471-0528.2004.00153.x. BJOG. 2004. PMID: 15198763 Clinical Trial.
Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
von Hertzen H, Piaggio G, Wojdyla D, Marions L, My Huong NT, Tang OS, Fang AH, Wu SC, Kalmar L, Mittal S, Erdenetungalag R, Horga M, Pretnar-Darovec A, Kapamadzija A, Dickson K, Anh ND, Tai NV, Tuyet HT, Peregoudov A; WHO Research Group on Post-ovulatory Methods of Fertility Regulation. von Hertzen H, et al. Among authors: pretnar darovec a. BJOG. 2009 Feb;116(3):381-9. doi: 10.1111/j.1471-0528.2008.02034.x. BJOG. 2009. PMID: 19187370 Clinical Trial.
WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy.
von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, Gopalan S, Horga M, Jerve F, Mittal S, Ngoc NT, Peregoudov A, Prasad RN, Pretnar-Darovec A, Shah RS, Song S, Tang OS, Wu SC; WHO Research Group on Post-Ovulatory Methods for Fertility Regulation. von Hertzen H, et al. Among authors: pretnar darovec a. BJOG. 2003 Sep;110(9):808-18. doi: 10.1111/j.1471-0528.2003.02430.x. BJOG. 2003. PMID: 14511962 Clinical Trial.
Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.
von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G, Ng E, Gemzell-Danielsson K, Oyunbileg A, Wu S, Cheng W, Lüdicke F, Pretnar-Darovec A, Kirkman R, Mittal S, Khomassuridze A, Apter D, Peregoudov A; WHO Research Group on Post-ovulatory Methods of Fertility Regulation. von Hertzen H, et al. Among authors: pretnar darovec a. Lancet. 2002 Dec 7;360(9348):1803-10. doi: 10.1016/S0140-6736(02)11767-3. Lancet. 2002. PMID: 12480356 Clinical Trial.
Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
von Hertzen H, Piaggio G, Wojdyla D, Nguyen TM, Marions L, Okoev G, Khomassuridze A, Kereszturi A, Mittal S, Nair R, Daver R, Pretnar-Darovec A, Dickson K, Nguyen DH, Nguyen HB, Hoang TD, Peregoudov A; WHO Research Group on Post-ovulatory Methods of Fertility Regulation. von Hertzen H, et al. Among authors: pretnar darovec a. Hum Reprod. 2009 Jan;24(1):106-12. doi: 10.1093/humrep/den328. Epub 2008 Sep 14. Hum Reprod. 2009. PMID: 18794161 Clinical Trial.
Postcoital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle. Task Force on Post-ovulatory Methods for Fertility Regulation.
Bhattacharjee SK, Romeo J, Kononova ES, Pretnar-Darovec A, Saraya L, Shi YE, Prasad RN, Bártfai G, Boukhris R, Van Look PF, et al. Bhattacharjee SK, et al. Among authors: pretnar darovec a. Contraception. 1987 Sep;36(3):275-86. doi: 10.1016/0010-7824(87)90097-7. Contraception. 1987. PMID: 3119286
A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.
Said S, Omar K, Koetsawang S, Kiriwat O, Srisatayapan Y, Kazi A, Ajmal F, Wynter HH, Pretnar-Darovec A, Benitez IB. Said S, et al. Among authors: pretnar darovec a. Contraception. 1987 Jun;35(6):591-610. doi: 10.1016/s0010-7824(87)80019-7. Contraception. 1987. PMID: 2959448 Clinical Trial.
A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction.
Said S, Omar K, Koetsawang S, Kiriwat O, Srisatayapan Y, Kazi A, Ajmal F, Wynter HH, Pretnar-Darovec A, Benitez IB, et al. Said S, et al. Contraception. 1986 Sep;34(3):223-35. doi: 10.1016/0010-7824(86)90004-1. Contraception. 1986. PMID: 2947777 Clinical Trial.
[Hormonal contraception (present status and prescribing].
Pretnar-Darovec A, Andolsek-Jeras L. Pretnar-Darovec A, et al. Jugosl Ginekol Perinatol. 1988 May-Aug;28(3-4):89-92. Jugosl Ginekol Perinatol. 1988. PMID: 3172836 Croatian. No abstract available.
13 results